AbbVie’s EPKINLY gains FDA nod for relapsed follicular lymphoma, offering new hope for patients
The full approval is based on the results from the pivotal Phase 3 EPCORE FL-1 study
The full approval is based on the results from the pivotal Phase 3 EPCORE FL-1 study
The formulation is backed by over 80 clinical trials and 200 scientific publications
The issue comprises a fresh issue of Rs. 95 crore and targeting a total raise of around Rs. 895 crore
SMDC is a participating authority under Pharmaceutical Inspection Cooperation Scheme (PIC/S)
The trial will evaluate safety endpoints including dose-limiting toxicities and adverse events
Cardiovascular disease (CVD) is the leading cause of death in the US and worldwide with over 82 million Americans living with CVD
Moraine will serve as OTSAW’s exclusive distributor in Japan, deploying the Camello+ autonomous mobile robot and TransCar autonomous guided vehicle to support hospital logistics
This partnership has led to a 10% boost in delivery speed
Subscribe To Our Newsletter & Stay Updated